Effectiveness of Motivation Skills Training (MST)
Public ClinicalTrials.gov record NCT05805397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Motivation Skills Training to Enhance Functional Outcomes for People With Schizophrenia
Study identification
- NCT ID
- NCT05805397
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Healthy Behaviors Control Group Behavioral
- Motivation Skills Training Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2024
- Primary completion
- Oct 30, 2026
- Completion
- Nov 29, 2026
- Last update posted
- Nov 4, 2025
2024 – 2026
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Bridge, Inc. | New York | New York | 10025 | Recruiting |
| New York State Office of Mental Health | New York | New York | 10032 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Schizoaffective Disorder trials
Other public records listing Schizoaffective Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07788755: NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia Not yet recruiting
- NCT07263022: Cognitive Strategies in Early Psychosis 2 Recruiting
- NCT07703670: MicroRNAs as Biomarkers in First Episode Schizophrenia Recruiting
- NCT06562608: Anticholinergic Deprescription in Schizophrenia Recruiting
- NCT07658391: Optimizing CBSST With Executive Function Training for Schizophrenia (R33) Not yet recruiting
- NCT04580134: CLOZAPINE Response in Biotype-1 Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05805397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05805397 live on ClinicalTrials.gov.